Chul Kim
0000-0003-0191-8684
9 papers found
Refreshing results…
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium
Use of Erdafitinib in FGFR3-Mutated Recurrent Respiratory Papillomatosis
Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer
Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung
Tarloxotinib is a hypoxia-activated pan-HER kinase inhibitor active against a broad range of HER-family oncogenes
Abscopal effect in pulmonary carcinoid tumor following ablative stereotactic body radiation therapy: a case report
Phase I study of the 177Lu-DOTA0-Tyr3-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung
First-line EGFR TKI therapy in non-small-cell lung cancer: looking back before leaping forward
Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection
Missing publications? Search for publications with a matching author name.